"GABAA RECEPTOR AND CELL MEMBRANE POTENTIAL AS FUNCTIONAL ENDPOINTS IN CULTURED NEURONS TO EVALUATE CHEMICALS FOR HUMAN ACUTE TOXICITY."
"OXIDATIVE STRESS AND ALTERED MITOCHONDRIAL FUNCTION IN NEURODEGENERATIVE DISEASES: LESSONS FROM MOUSE MODELS."
"REDUCED SIGNAL TRANSDUCTION BY 5-HT4 RECEPTORS AFTER LONG-TERM VENLAFAXINE TREATMENT IN RATS."
"D2 AND D4 DOPAMINE RECEPTOR MRNA DISTRIBUTION IN PYRAMIDAL NEURONS AND GABAERGIC SUBPOPULATIONS IN MONKEY PREFRONTAL CORTEX: IMPLICATIONS FOR SCHIZOPHRENIA TREATMENT."
"FISH PROTEOME ANALYSIS: MODEL ORGANISMS AND NON-SEQUENCED SPECIES."
"NUCLEAR TRANSLOCATION OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE IS REGULATED BY ACETYLATION."
"REDOX CONTROL OF LIVER FUNCTION IN HEALTH AND DISEASE."
"CHONDROITIN SULFATE INHIBITS LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION IN RAT ASTROCYTES BY PREVENTING NUCLEAR FACTOR KAPPA B ACTIVATION."
"EXTENDED ISCHEMIA PREVENTS HIF1ALPHA DEGRADATION AT REOXYGENATION BY IMPAIRING PROLYL-HYDROXYLATION: ROLE OF KREBS CYCLE METABOLITES."
"NEW STRATEGIES IN THE SEARCH OF ANTIPSYCHOTIC DRUGS."
ALCOHOL, SIGNALING, AND ECM TURNOVER.
"CHOLESTEROL AND PEROXIDIZED CARDIOLIPIN IN MITOCHONDRIAL MEMBRANE PROPERTIES, PERMEABILIZATION AND CELL DEATH."
"DOPAMINE RELEASE INDUCED BY ATYPICAL ANTIPSYCHOTICS IN PREFRONTAL CORTEX REQUIRES 5-HT(1A)RECEPTORS BUT NOT 5-HT(2A)RECEPTORS."
"NEW INSIGHTS INTO FATTY LIVER PRESERVATION USING INSTITUTE GEORGES LOPEZ PRESERVATION SOLUTION."
"USE OF GENE EXPRESSION OF NEURAL MARKERS IN CULTURED NEURAL CELLS TO IDENTIFY DEVELOPMENTAL NEUROTOXICANTS."
"CHARACTERIZATION OF THE HUMAN PLASMA PHOSPHOPROTEOME USING LINEAR ION TRAP MASS SPECTROMETRY AND MULTIPLE SEARCH ENGINES."
"MATRIX METALLOPROTEINASE 2 IN REDUCED-SIZE LIVER TRANSPLANTATION: BEYOND THE MATRIX."
"MODIFIED C-REACTIVE PROTEIN IS EXPRESSED BY STROKE NEOVESSELS AND IS A POTENT ACTIVATOR OF ANGIOGENESIS IN VITRO."
"UNRAVELING MONOAMINE RECEPTORS INVOLVED IN THE ACTION OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON GLUTAMATERGIC AND SEROTONERGIC TRANSMISSION IN PREFRONTAL CORTEX."
"CHARACTERIZATION OF PEPTIDES AND PROTEINS IN COMMERCIAL HSA SOLUTIONS."
